{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:22:43Z","timestamp":1792290163169,"version":"4.4.0"},"reference-count":34,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2022,5,31]]},"DOI":"10.7883\/yoken.jjid.2021.505","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T22:13:21Z","timestamp":1632953601000},"page":"254-261","source":"Crossref","is-referenced-by-count":6,"title":["Trends in Systemic Antifungal Use in Australia, 2005\u20132016: a Time-Series Analysis"],"prefix":"10.7883","volume":"75","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, China"},{"name":"School of Pharmacy, Faculty of Medicine, University of Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke L.","family":"Van Driel","sequence":"additional","affiliation":[{"name":"Primary Care Clinical Unit, Faculty of Medicine, University of Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Treasure M.","family":"McGuire","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine, University of Queensland, Australia"},{"name":"Faculty of Health Sciences &amp; Medicine, Bond University, Australia"},{"name":"Mater Pharmacy, Mater Health, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A.","family":"Hollingworth","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine, University of Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Valerio M, Munoz P, Rodriguez CG, et al. Antifungal stewardship in a tertiary-care institution: a bedside intervention. Clin Microbiol Infect. 2015;21:492.e1-9.","DOI":"10.1016\/j.cmi.2015.01.013"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nivoix Y, Launoy A, Lutun P, et al. Adherence to recommendations for the use of antifungal agents in a tertiary care hospital. J Antimicrob Chemother. 2012;67:2506-2513.","DOI":"10.1093\/jac\/dks256"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Valerio M, Rodriguez-Gonzalez CG, Mu\u00f1oz P, et al. Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed. J Antimicrob Chemother. 2014;69:1993-1999.","DOI":"10.1093\/jac\/dku053"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mu\u00f1oz P, Bouza E on behalf of the COMIC (collaboration group on mycosis) study group. The current treatment landscape: the need for antifungal stewardship programmes. J Antimicrob Chemother. 2016;71:ii5-ii12.","DOI":"10.1093\/jac\/dkw391"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Fisher MC, Hawkins NJ, Sanglard D, et al. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science. 2018;360:739-742.","DOI":"10.1126\/science.aap7999"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused by <i>Scedosporium<\/i> spp. Clin Microbiol Rev. 2008;21:157-197.","DOI":"10.1128\/CMR.00039-07"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17:e383-e392.","DOI":"10.1016\/S1473-3099(17)30316-X"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Vallabhaneni S, Baggs J, Tsay S, et al. Trends in antifungal use in US hospitals, 2006\u201312. J Antimicrob Chemother. 2018;73:2867-2875.","DOI":"10.1093\/jac\/dky270"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Natari RB, McGuire TM, Baker PJ, et al. Longitudinal impact of the Women&apos;s Health Initiative study on hormone therapy use in Australia. Climacteric. 2019;22:489-497.","DOI":"10.1080\/13697137.2019.1593357"},{"key":"10","unstructured":"10. Adelaide (SA): Australian Medicines Handbook Pty Ltd. Australian Medicines Handbook. Available at &lt;https:\/\/amhonline-amh-net-au.ezproxy.library.uwa.edu.au\/chapters\/anti-infectives\/antifungals&gt;. Accessed December 9, 2019."},{"key":"11","unstructured":"11. Department of Human Services, Australian Government. Statistical information and data. Available at &lt;https:\/\/www.humanservices.gov.au\/corporate\/statistical-information-and-data&gt;. Accessed March 10, 2022."},{"key":"12","unstructured":"12. Department of Health, Australian Government. Australian Statistics on Medicines 2015. Available at &lt;https:\/\/www.pbs.gov.au\/info\/statistics\/asm\/asm-2015&gt;. Accessed March 23, 2022."},{"key":"13","unstructured":"13. Department of Human Services, Australian Government. Pharmaceutical Benefit Schedule item statistics. Available at &lt;http:\/\/medicarestatistics.humanservices.gov.au\/statistics\/pbs_item.jsp&gt;. Accessed February 24, 2017."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bailly S, Maubon D, Fournier P, et al. Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years. J Infect. 2016;72:103-111.","DOI":"10.1016\/j.jinf.2015.09.041"},{"key":"15","unstructured":"15. World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index. Available at &lt;https:\/\/www.whocc.no\/atc_ddd_index\/&gt;. Accessed February 24, 2017."},{"key":"16","unstructured":"16. Department of Social Services, Australian Goverment. Annual reports 2016. Available at &lt;http:\/\/www.dss.gov.au\/about-the-department\/publications-articles\/corporate-publications\/annual-reports&gt;. Accessed February 24, 2017."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Helfenstein U. Box-Jenkins modelling in medical research. Stat Methods Med Res. 1996;5:3-22.","DOI":"10.1177\/096228029600500102"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Aldeyab MA, Monnet DL, Lopez-Lozano JM, et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother. 2008;62:593-600.","DOI":"10.1093\/jac\/dkn198"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Gross BN, Steib-Bauert M, Kern WV, et al. Hospital use of systemic antifungal drugs: a multi-center surveillance update from Germany. Infection. 2015;43:423-429.","DOI":"10.1007\/s15010-015-0742-5"},{"key":"20","unstructured":"20. Olaechea-Astigarraga PM, Alvarez-Lerma F, Palomar-Martinez M, et al. Trends in systemic antifungal use in critically ill patients. Multicenter observational study, 2006\u20132010. Enferm Infecc Microbiol Clin. 2012;30:435-440. Spanish."},{"key":"21","unstructured":"21. Australian Institute of Health and Welfare. Cancer data in Australia. Available at &lt;https:\/\/www.aihw.gov.au\/reports\/cancer\/cancer-data-in-australia\/contents\/about&gt;. Accessed February 3, 2022."},{"key":"22","unstructured":"22. Australian Government Organ and Tissue Authority. Australian donation and transplantation activity report 2016. Available at &lt;https:\/\/www.donatelife.gov.au\/sites\/default\/files\/2021-05\/australian_donation_and_transplantation_activity_report_2016.pdf&gt;. Accessed April 21, 2022."},{"key":"23","unstructured":"23. Ruseckaite R, Ahern S, Tom Ranger T, et al. Australian cystic fibrosis data registry annual report 2016. Available at &lt;https:\/\/research.monash.edu\/en\/publications\/australian-cystic-fibrosis-data-registry-annual-report-2016&gt;. Accessed February 3, 2022."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ward J, McManus H, McGregor S, et al. HIV incidence in Indigenous and non-Indigenous populations in Australia: a population-level observational study. Lancet HIV. 2018;5:e506-e514.","DOI":"10.1016\/S2352-3018(18)30135-8"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Chapman B, Slavin M, Marriott D, et al. Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother. 2017;72:1103-1108.","DOI":"10.1093\/jac\/dkx047"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Gupta AK, Foley KA, Versteeg SG. New antifungal agents and new formulations against dermatophytes. Mycopathologia. 2017;182:127-141.","DOI":"10.1007\/s11046-016-0045-0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hachem R, Assaf A, Numan Y, et al. Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies. Int J Antimicrob Agents. 2017;50:384-388.","DOI":"10.1016\/j.ijantimicag.2017.03.021"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Nivison-Smith I, Bardy P, Dodds AJ, et al. A review of hematopoietic cell transplantation in Australia and New Zealand, 2005 to 2013. Biol Blood Marrow Transplant. 2016;22:284-291.","DOI":"10.1016\/j.bbmt.2015.09.009"},{"key":"29","unstructured":"29. Australian Government, Department of Health. Schedule of pharmaceutical benefits. Available at &lt;https:\/\/meteor.aihw.gov.au\/content\/index.phtml\/itemId\/600767&gt;. Accessed February 3, 2022."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Wang Y, McGuire TM, Hollingworth SA, et al. Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: what do the guidelines recommend? Int J Infect Dis. 2019;89:137-145.","DOI":"10.1016\/j.ijid.2019.10.016"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Schneider CR, Emery L, Brostek R, et al. Evaluation of the supply of antifungal medication for the treatment of vaginal thrush in the community pharmacy setting: a randomized controlled trial. Pharm Pract (Granada). 2013;11:132-137.","DOI":"10.4321\/S1886-36552013000300002"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Sutepvarnon A, Apisarnthanarak A, Camins B, et al. Inappropriate use of antifungal medications in a tertiary care center in Thailand: a prospective study. Infect Control Hosp Epidemiol. 2008;29:370-373.","DOI":"10.1086\/587633"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Pfaller MA, Castanheira M, Messer SA, et al. Variation in <i>Candida<\/i> spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008\u20132009). Diagn Microbiol Infect Dis. 2010;68:278-283.","DOI":"10.1016\/j.diagmicrobio.2010.06.015"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1-50.","DOI":"10.1093\/cid\/civ933"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/75\/3\/75_JJID.2021.505\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:23:07Z","timestamp":1715232187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/75\/3\/75_JJID.2021.505\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2021.505","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"article-number":"JJID.2021.505"}}